Hi savvy, you are correct this is only pre clinical and that it...

Hi savvy, you are correct this is only pre clinical and that it is a long way from launch. But it’s not long until SPL will receive milestone payments from AZ, as it goes into the clinic and progresses. Most importantly it is further proof of concept and supports the ‘optionality’ of DEP technology. Proof of concept in partnership with a global pharmaceutical company!

They have DEP doc in phase II already, which they will licence out at completion of phase II which i’d expect in 2019. The pipeline of SPLs DEP technology is large and very lucrative.

I don’t think the price will drift down again, I think this is our next leg up. Especially if we get vivagel licensing news soon.